Loading…
Angiotensin-[1-12] interacts with angiotensin type I receptors
Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected w...
Saved in:
Published in: | Neuropharmacology 2014-06, Vol.81, p.267-273 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093 |
---|---|
cites | cdi_FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093 |
container_end_page | 273 |
container_issue | |
container_start_page | 267 |
container_title | Neuropharmacology |
container_volume | 81 |
creator | Chan, King H. Chen, Yi H. Zhang, Ying Wong, Yung H. Dun, Nae J. |
description | Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected with 5 μg AT1R by monitoring [Ca2+]i using the Fluo-4. Ang II (1 pM–1 μM) and Ang-(1–12) (5 pM–5 μM) increased [Ca2+]i with an EC50 of 0.19 nM and 24 nM in COS-7 cells; and 0.65 nM and 28.7 nM in CHO cells. The AT1R antagonist losartan (1 nM–10 μM) suppressed [Ca2+]i induced by Ang-(1–12) and Ang II. In CHO cells transfected with 5 μg AT2R, Ang II (1 pM-1 μM) increased [Ca2+]i, with an EC50 of 9.68 nM; whereas, Ang-(1–12) (5 pM–5 μM) failed to elicit a significant change in [Ca2+]i. In CHO cells transfected with AT1R, Ang-(1–12) stimulated ERK phosphorylation with a potency 300-fold less than that of Ang II. To evaluate the activity of Ang-(1–12) on native AT1R, whole cell patch recordings were made from neurons in the rat hypothalamic slices. Ang II or Ang-(1–12) ejected by pressure from a micropipette elicited a membrane depolarization; the latter was blocked by losartan (10 μM), and not affected by the AT2R antagonist PD123319 (10 μM), nor by the angiotensin converting enzyme inhibitor captopril (10 μM). Our result shows that Ang-(1–12) may produce its biological activity by acting directly on AT1R, albeit at a concentration higher than that of Ang II.
•Ang-(1–12) or Ang II mobilizes Ca2+ in cell lines transfected with AT1R cDNA.•Ang-(1–12) or Ang II induces ERK phosphorylation in cell lines.•Ang-(1–12) or Ang II depolarize neurons in rat hypothalamic slices.•Ang-(1–12) depolarization is suppressed by losartan and not affected by captopril.•Ang-(1-12) may directly act on AT1R, in addition to being a precursor to the formation of Ang I and Ang II. |
doi_str_mv | 10.1016/j.neuropharm.2013.06.022 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3823637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390813002906</els_id><sourcerecordid>1534848349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093</originalsourceid><addsrcrecordid>eNqFkE1PGzEQhi1URELav1DtsZfdztgbr_cSKUWFIiFxgRNCluOdEEeJvbUdEP--G4WvnjjNYd6PmYexAqFCQPlzXXnaxdCvTNxWHFBUICvg_IiNUTWibEDWX9gYgKtStKBG7DSlNQDUCtUJG3GhuGibdsxmc__gQiafnC_vsER-XzifKRqbU_Hk8qow74oiP_dUXBaRLPU5xPSVHS_NJtG3lzlht-e_b87-lFfXF5dn86vSTpHnkkvshBWqswKXfNE1ArFtuZpOjcSF6YDXjZFmOEuBbG29sIgSbVc3SzQErZiw2SG33y221FnyOZqN7qPbmvisg3H6_413K_0QHvX-USmaIeDHS0AMf3eUst66ZGmzMZ7CLmmcilrVStT7LnWQ2hhSirR8q0HQe_x6rd_x6z1-DVIP-Afr949nvhlfeQ-CXwcBDbAeHUWdrCNvqXMD06y74D5v-QdYg5wh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1534848349</pqid></control><display><type>article</type><title>Angiotensin-[1-12] interacts with angiotensin type I receptors</title><source>ScienceDirect Freedom Collection</source><creator>Chan, King H. ; Chen, Yi H. ; Zhang, Ying ; Wong, Yung H. ; Dun, Nae J.</creator><creatorcontrib>Chan, King H. ; Chen, Yi H. ; Zhang, Ying ; Wong, Yung H. ; Dun, Nae J.</creatorcontrib><description>Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected with 5 μg AT1R by monitoring [Ca2+]i using the Fluo-4. Ang II (1 pM–1 μM) and Ang-(1–12) (5 pM–5 μM) increased [Ca2+]i with an EC50 of 0.19 nM and 24 nM in COS-7 cells; and 0.65 nM and 28.7 nM in CHO cells. The AT1R antagonist losartan (1 nM–10 μM) suppressed [Ca2+]i induced by Ang-(1–12) and Ang II. In CHO cells transfected with 5 μg AT2R, Ang II (1 pM-1 μM) increased [Ca2+]i, with an EC50 of 9.68 nM; whereas, Ang-(1–12) (5 pM–5 μM) failed to elicit a significant change in [Ca2+]i. In CHO cells transfected with AT1R, Ang-(1–12) stimulated ERK phosphorylation with a potency 300-fold less than that of Ang II. To evaluate the activity of Ang-(1–12) on native AT1R, whole cell patch recordings were made from neurons in the rat hypothalamic slices. Ang II or Ang-(1–12) ejected by pressure from a micropipette elicited a membrane depolarization; the latter was blocked by losartan (10 μM), and not affected by the AT2R antagonist PD123319 (10 μM), nor by the angiotensin converting enzyme inhibitor captopril (10 μM). Our result shows that Ang-(1–12) may produce its biological activity by acting directly on AT1R, albeit at a concentration higher than that of Ang II.
•Ang-(1–12) or Ang II mobilizes Ca2+ in cell lines transfected with AT1R cDNA.•Ang-(1–12) or Ang II induces ERK phosphorylation in cell lines.•Ang-(1–12) or Ang II depolarize neurons in rat hypothalamic slices.•Ang-(1–12) depolarization is suppressed by losartan and not affected by captopril.•Ang-(1-12) may directly act on AT1R, in addition to being a precursor to the formation of Ang I and Ang II.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2013.06.022</identifier><identifier>PMID: 23823979</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>ACE inhibitor ; Angiotensin I - pharmacology ; Angiotensin II ; Angiotensin II - pharmacology ; Angiotensinogen - pharmacology ; Animals ; Animals, Newborn ; CHO Cells ; Cricetulus ; Dose-Response Relationship, Drug ; Extracellular Signal-Regulated MAP Kinases - metabolism ; Female ; G-protein ; Gene Expression Regulation - drug effects ; Hypothalamus ; Male ; Membrane Potentials - drug effects ; Peptide Fragments - pharmacology ; Phosphorylation - drug effects ; Protein Binding - drug effects ; Rats ; Rats, Sprague-Dawley ; Receptor, Angiotensin, Type 1 - genetics ; Receptor, Angiotensin, Type 1 - metabolism ; Transfection</subject><ispartof>Neuropharmacology, 2014-06, Vol.81, p.267-273</ispartof><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>2013 Elsevier Ltd. All rights reserved 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093</citedby><cites>FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23823979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, King H.</creatorcontrib><creatorcontrib>Chen, Yi H.</creatorcontrib><creatorcontrib>Zhang, Ying</creatorcontrib><creatorcontrib>Wong, Yung H.</creatorcontrib><creatorcontrib>Dun, Nae J.</creatorcontrib><title>Angiotensin-[1-12] interacts with angiotensin type I receptors</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected with 5 μg AT1R by monitoring [Ca2+]i using the Fluo-4. Ang II (1 pM–1 μM) and Ang-(1–12) (5 pM–5 μM) increased [Ca2+]i with an EC50 of 0.19 nM and 24 nM in COS-7 cells; and 0.65 nM and 28.7 nM in CHO cells. The AT1R antagonist losartan (1 nM–10 μM) suppressed [Ca2+]i induced by Ang-(1–12) and Ang II. In CHO cells transfected with 5 μg AT2R, Ang II (1 pM-1 μM) increased [Ca2+]i, with an EC50 of 9.68 nM; whereas, Ang-(1–12) (5 pM–5 μM) failed to elicit a significant change in [Ca2+]i. In CHO cells transfected with AT1R, Ang-(1–12) stimulated ERK phosphorylation with a potency 300-fold less than that of Ang II. To evaluate the activity of Ang-(1–12) on native AT1R, whole cell patch recordings were made from neurons in the rat hypothalamic slices. Ang II or Ang-(1–12) ejected by pressure from a micropipette elicited a membrane depolarization; the latter was blocked by losartan (10 μM), and not affected by the AT2R antagonist PD123319 (10 μM), nor by the angiotensin converting enzyme inhibitor captopril (10 μM). Our result shows that Ang-(1–12) may produce its biological activity by acting directly on AT1R, albeit at a concentration higher than that of Ang II.
•Ang-(1–12) or Ang II mobilizes Ca2+ in cell lines transfected with AT1R cDNA.•Ang-(1–12) or Ang II induces ERK phosphorylation in cell lines.•Ang-(1–12) or Ang II depolarize neurons in rat hypothalamic slices.•Ang-(1–12) depolarization is suppressed by losartan and not affected by captopril.•Ang-(1-12) may directly act on AT1R, in addition to being a precursor to the formation of Ang I and Ang II.</description><subject>ACE inhibitor</subject><subject>Angiotensin I - pharmacology</subject><subject>Angiotensin II</subject><subject>Angiotensin II - pharmacology</subject><subject>Angiotensinogen - pharmacology</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>CHO Cells</subject><subject>Cricetulus</subject><subject>Dose-Response Relationship, Drug</subject><subject>Extracellular Signal-Regulated MAP Kinases - metabolism</subject><subject>Female</subject><subject>G-protein</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Hypothalamus</subject><subject>Male</subject><subject>Membrane Potentials - drug effects</subject><subject>Peptide Fragments - pharmacology</subject><subject>Phosphorylation - drug effects</subject><subject>Protein Binding - drug effects</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Angiotensin, Type 1 - genetics</subject><subject>Receptor, Angiotensin, Type 1 - metabolism</subject><subject>Transfection</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkE1PGzEQhi1URELav1DtsZfdztgbr_cSKUWFIiFxgRNCluOdEEeJvbUdEP--G4WvnjjNYd6PmYexAqFCQPlzXXnaxdCvTNxWHFBUICvg_IiNUTWibEDWX9gYgKtStKBG7DSlNQDUCtUJG3GhuGibdsxmc__gQiafnC_vsER-XzifKRqbU_Hk8qow74oiP_dUXBaRLPU5xPSVHS_NJtG3lzlht-e_b87-lFfXF5dn86vSTpHnkkvshBWqswKXfNE1ArFtuZpOjcSF6YDXjZFmOEuBbG29sIgSbVc3SzQErZiw2SG33y221FnyOZqN7qPbmvisg3H6_413K_0QHvX-USmaIeDHS0AMf3eUst66ZGmzMZ7CLmmcilrVStT7LnWQ2hhSirR8q0HQe_x6rd_x6z1-DVIP-Afr949nvhlfeQ-CXwcBDbAeHUWdrCNvqXMD06y74D5v-QdYg5wh</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Chan, King H.</creator><creator>Chen, Yi H.</creator><creator>Zhang, Ying</creator><creator>Wong, Yung H.</creator><creator>Dun, Nae J.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20140601</creationdate><title>Angiotensin-[1-12] interacts with angiotensin type I receptors</title><author>Chan, King H. ; Chen, Yi H. ; Zhang, Ying ; Wong, Yung H. ; Dun, Nae J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>ACE inhibitor</topic><topic>Angiotensin I - pharmacology</topic><topic>Angiotensin II</topic><topic>Angiotensin II - pharmacology</topic><topic>Angiotensinogen - pharmacology</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>CHO Cells</topic><topic>Cricetulus</topic><topic>Dose-Response Relationship, Drug</topic><topic>Extracellular Signal-Regulated MAP Kinases - metabolism</topic><topic>Female</topic><topic>G-protein</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Hypothalamus</topic><topic>Male</topic><topic>Membrane Potentials - drug effects</topic><topic>Peptide Fragments - pharmacology</topic><topic>Phosphorylation - drug effects</topic><topic>Protein Binding - drug effects</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Angiotensin, Type 1 - genetics</topic><topic>Receptor, Angiotensin, Type 1 - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, King H.</creatorcontrib><creatorcontrib>Chen, Yi H.</creatorcontrib><creatorcontrib>Zhang, Ying</creatorcontrib><creatorcontrib>Wong, Yung H.</creatorcontrib><creatorcontrib>Dun, Nae J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, King H.</au><au>Chen, Yi H.</au><au>Zhang, Ying</au><au>Wong, Yung H.</au><au>Dun, Nae J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin-[1-12] interacts with angiotensin type I receptors</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>81</volume><spage>267</spage><epage>273</epage><pages>267-273</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected with 5 μg AT1R by monitoring [Ca2+]i using the Fluo-4. Ang II (1 pM–1 μM) and Ang-(1–12) (5 pM–5 μM) increased [Ca2+]i with an EC50 of 0.19 nM and 24 nM in COS-7 cells; and 0.65 nM and 28.7 nM in CHO cells. The AT1R antagonist losartan (1 nM–10 μM) suppressed [Ca2+]i induced by Ang-(1–12) and Ang II. In CHO cells transfected with 5 μg AT2R, Ang II (1 pM-1 μM) increased [Ca2+]i, with an EC50 of 9.68 nM; whereas, Ang-(1–12) (5 pM–5 μM) failed to elicit a significant change in [Ca2+]i. In CHO cells transfected with AT1R, Ang-(1–12) stimulated ERK phosphorylation with a potency 300-fold less than that of Ang II. To evaluate the activity of Ang-(1–12) on native AT1R, whole cell patch recordings were made from neurons in the rat hypothalamic slices. Ang II or Ang-(1–12) ejected by pressure from a micropipette elicited a membrane depolarization; the latter was blocked by losartan (10 μM), and not affected by the AT2R antagonist PD123319 (10 μM), nor by the angiotensin converting enzyme inhibitor captopril (10 μM). Our result shows that Ang-(1–12) may produce its biological activity by acting directly on AT1R, albeit at a concentration higher than that of Ang II.
•Ang-(1–12) or Ang II mobilizes Ca2+ in cell lines transfected with AT1R cDNA.•Ang-(1–12) or Ang II induces ERK phosphorylation in cell lines.•Ang-(1–12) or Ang II depolarize neurons in rat hypothalamic slices.•Ang-(1–12) depolarization is suppressed by losartan and not affected by captopril.•Ang-(1-12) may directly act on AT1R, in addition to being a precursor to the formation of Ang I and Ang II.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23823979</pmid><doi>10.1016/j.neuropharm.2013.06.022</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3908 |
ispartof | Neuropharmacology, 2014-06, Vol.81, p.267-273 |
issn | 0028-3908 1873-7064 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3823637 |
source | ScienceDirect Freedom Collection |
subjects | ACE inhibitor Angiotensin I - pharmacology Angiotensin II Angiotensin II - pharmacology Angiotensinogen - pharmacology Animals Animals, Newborn CHO Cells Cricetulus Dose-Response Relationship, Drug Extracellular Signal-Regulated MAP Kinases - metabolism Female G-protein Gene Expression Regulation - drug effects Hypothalamus Male Membrane Potentials - drug effects Peptide Fragments - pharmacology Phosphorylation - drug effects Protein Binding - drug effects Rats Rats, Sprague-Dawley Receptor, Angiotensin, Type 1 - genetics Receptor, Angiotensin, Type 1 - metabolism Transfection |
title | Angiotensin-[1-12] interacts with angiotensin type I receptors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T01%3A05%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin-%5B1-12%5D%20interacts%20with%20angiotensin%20type%20I%20receptors&rft.jtitle=Neuropharmacology&rft.au=Chan,%20King%20H.&rft.date=2014-06-01&rft.volume=81&rft.spage=267&rft.epage=273&rft.pages=267-273&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2013.06.022&rft_dat=%3Cproquest_pubme%3E1534848349%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1534848349&rft_id=info:pmid/23823979&rfr_iscdi=true |